Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Reexamination Certificate
2011-04-19
2011-04-19
Gambel, Phillip (Department: 1644)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
C424S130100, C424S133100, C424S141100, C424S152100, C424S158100, C530S387100, C530S387300, C530S388200, C530S388240
Reexamination Certificate
active
07927593
ABSTRACT:
The present invention provides very high affinity antibodies, or antigen-binding fragments thereof, that neutralize mature human TGF-β1, TGF-β2, and TGF-β3. The antibodies of the invention are useful for treating cell proliferative disorders in a mammal.
REFERENCES:
patent: 7494651 (2009-02-01), Jones et al.
patent: 2005/097832 (2005-10-01), None
Carlsson, et al., “n-CoDer concept: Unique Types of Antibodies for Diagnostic Use and Therapy,” Expert Review of Molecular Diagnostics 1(1): 102-108 (2001).
Carruthers, et al, “In vitro and in vivo characterization of CAT-192 and ID11: Neutralising antibodies to transforming growth factor beta,” British Journal of Pharmacology 135(Proceedings Supp.);265p (Mar. 2002).
Hoefer, et al., “Anti-(Transforming Growth Factor Beta) Antibodies with Predefined Specificity Inhibit Metastasis of Highly Tumorigenic Human Xenotransplants in Nu/Nu Mice,” Cancer Immunology and Immunotherapy 41(5):302-308 (1995).
Shah, et al., “Neutralisation of TGF-Beta1 and TGF-Beta2 or Exogenous Addition of TGF-Beta3 to Cutaneous Rat Wounds Reduces Scarring,” Journal of Cell Science 108(Part 3):985-1002 (1995).
Wolleheim, et al., “Sixth International Workshop on Scleroderma Research,” Arthritis Research 3:34-40 (2001).
Padua et al., Cell Research 19: 89-1 02, 2009.
Varga et al., Curr Opin Rheumatol 20: 720-728, 2008.
Khan, Cardiology 108: 368-380, 2007.
Jones Bryan Edward
Pancook James David
Rowlinson Scott William
Eli Lilly and Company
Gambel Phillip
Sharp Robert L.
LandOfFree
TGF-beta binding antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with TGF-beta binding antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and TGF-beta binding antibodies will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2619810